Study guide
18.1 Rheumatoid Arthritis: Pathophysiology, Clinical Features & Diagnosis
MRCP UK
Track your progress as you read
Finished sections get a check mark.
1 MRCP(UK) Part 1: Exam Overview, Blueprint & Strategy
1.1 Part 1 Format, Delivery and Fees 1.2 The Official Blueprint and Mark Allocation 1.3 Scaled Scoring, Attempt Limits and Best-of-Five Technique
2 Clinical Sciences: Cellular, Genetic & Molecular Medicine
2.1 Organelles, Cytoskeleton & Membrane Transport 2.2 Cell Cycle Control, Apoptosis & Cell Signalling 2.3 Mendelian & Non-Mendelian Inheritance 2.4 Trinucleotide Repeat Disorders & Chromosomal Abnormalities 2.5 Purine, Pyrimidine Metabolism & the Porphyrias 2.6 Glycogen, Lipid Storage & Amino Acid Disorders
3 Clinical Sciences: Anatomy, Physiology & Immunology
3.1 Clinical & Cross-Sectional Anatomy 3.2 Systemic Clinical Physiology & Homeostasis 3.3 Clinical Immunology & Hypersensitivity Reactions
4 Clinical Sciences: Statistics, Epidemiology & Trial Design
4.1 Study Designs & Evidence Hierarchy 4.2 Diagnostic Testing, Screening & Predictive Values 4.3 Statistical Analysis & Risk Quantification
5 Clinical Pharmacology, Therapeutics & Toxicology
5.1 Pharmacokinetics & Pharmacodynamics 5.2 Cytochrome P450 Systems & High-Risk Drug Interactions 5.3 Adverse Drug Reactions & Therapeutic Drug Monitoring 5.4 Paracetamol & Salicylate Poisoning 5.5 Toxidromes, Antidotes, Carbon Monoxide & Toxic Alcohols
6 Cardiology: Coronary Artery Disease & Heart Failure
6.1 Acute Coronary Syndromes & Myocardial Infarction 6.2 Heart Failure & Cardiomyopathies 6.3 Cardiac Assessment & ECG Interpretation
7 Cardiology: Arrhythmias, Valvular & Pericardial Disease
7.1 Atrial Fibrillation, Narrow & Broad Complex Tachycardias 7.2 Bradyarrhythmias, Conduction Block & Antiarrhythmic Drugs 7.3 Valvular Heart Disease & Murmur Interpretation 7.4 Infective Endocarditis 7.5 Pericardial & Acute Aortic Diseases
8 Respiratory Medicine: Airway & Parenchymal Lung Disease
8.1 Asthma: Diagnosis, Chronic Management & Acute Attacks 8.2 COPD: GOLD Staging, Stable Management, Exacerbations & NIV 8.3 Interstitial Lung Disease & Sarcoidosis 8.4 Respiratory Infections & Bronchiectasis
9 Respiratory Medicine: Vascular, Pleural & Sleep Disorders
9.1 Venous Thromboembolism & Pulmonary Embolism 9.2 Pleural Effusion & Pneumothorax 9.3 Respiratory Failure & Sleep-Disordered Breathing
10 Gastroenterology: Luminal Gastrointestinal Disease
10.1 GORD, Barrett's Oesophagus & Oesophageal Motility Disorders 10.2 Peptic Ulcer Disease, Helicobacter pylori & Zollinger-Ellison Syndrome 10.3 Crohn's Disease, Ulcerative Colitis & Extraintestinal Manifestations 10.4 IBD Medical Therapy, Coeliac Disease & Malabsorption 10.5 Acute Upper Gastrointestinal Bleeding: Risk Scores, Ulcer & Variceal Haemorrhage 10.6 Lower Gastrointestinal Disorders & Colonic Neoplasia
11 Gastroenterology: Liver, Biliary & Pancreatic Disease
11.1 Viral Hepatitis A to E 11.2 Autoimmune Hepatitis & Metabolic Liver Disease 11.3 Cirrhosis & Complications of Portal Hypertension 11.4 Cholestatic Liver Disease: PBC and PSC 11.5 Gallstone Disease, Biliary Sepsis & Pancreatitis
12 Endocrinology & Diabetes: Diabetes & Thyroid
12.1 Diabetes: Diagnostic Thresholds, Classification & Pathophysiology 12.2 NICE-Directed Type 2 Therapy & Microvascular Complications 12.3 Acute Diabetic Emergencies (DKA & HHS) 12.4 Thyrotoxicosis, Thyroiditis & Management of Hyperthyroidism 12.5 Hypothyroidism, Subclinical Disease & Thyroid Nodules
13 Endocrinology & Diabetes: Adrenal, Pituitary & Calcium
13.1 Hypopituitarism, Pituitary Apoplexy & Hyperprolactinaemia 13.2 Acromegaly, Diabetes Insipidus & SIADH 13.3 Cushing's Syndrome: Aetiology, Screening & Localisation 13.4 Adrenal Insufficiency & Endocrine Hypertension 13.5 Calcium Regulation & Hypercalcaemia 13.6 Hypocalcaemia & Metabolic Bone Disease
14 Renal Medicine: AKI, Glomerular & Tubulointerstitial Disease
14.1 Acute Kidney Injury & Chronic Kidney Disease 14.2 Nephrotic and Nephritic Syndromes & Primary Glomerular Disease 14.3 Rapidly Progressive Glomerulonephritis 14.4 Tubulointerstitial & Inherited Renal Diseases
15 Renal Medicine: Fluid, Electrolytes & Acid-Base Balance
15.1 Sodium & Water Disorders 15.2 Potassium, Magnesium & Phosphate Disorders 15.3 Acid-Base Disorders & Blood Gas Analysis
16 Neurology: Cerebrovascular, Headache & Demyelinating Disease
16.1 Stroke Classification, Brainstem Syndromes & Hyperacute Reperfusion 16.2 Secondary Prevention, TIA, Carotid Surgery & Intracranial Haemorrhage 16.3 Headache Disorders & Cranial Neuralgias 16.4 Multiple Sclerosis & Central Demyelinating Diseases
17 Neurology: Epilepsy, Movement Disorders & Neuromuscular Disease
17.1 Epilepsy & Acute Seizures 17.2 Movement Disorders & Cognitive Impairment 17.3 Neuromuscular Junction & Peripheral Nerve Disorders
18 Rheumatology: Inflammatory Arthritis & Connective Tissue Disease
18.1 Rheumatoid Arthritis: Pathophysiology, Clinical Features & Diagnosis 18.2 DMARDs, Biologics & Their Toxicities 18.3 Seronegative Spondyloarthropathies 18.4 Systemic Lupus Erythematosus & Drug-Induced Lupus 18.5 Systemic Sclerosis & Scleroderma Renal Crisis 18.6 Sjogren's Syndrome & Inflammatory Myopathies
19 Rheumatology: Systemic Vasculitis & Crystal Arthropathy
19.1 Vasculitis Classification, Large and Medium Vessel Disease 19.2 ANCA-Associated and Immune Complex Small Vessel Vasculitis 19.3 Gout & Calcium Pyrophosphate Deposition Disease
20 Infectious Diseases & Tropical Medicine
20.1 Sepsis-3 Definitions & the Sepsis Six 20.2 Bacterial Meningitis, CSF Interpretation & Toxic Shock Syndrome 20.3 Tuberculosis: Pathogenesis & Clinical Manifestations 20.4 Tuberculosis: Diagnosis & Anti-Tuberculous Therapy 20.5 HIV Infection & Opportunistic Diseases 20.6 Malaria: Species, Life Cycle & Severe Disease 20.7 Enteric Fever, Arboviral Infection & Tissue Parasites
21 Haematology: Anaemias & Red Cell Disorders
21.1 MCV-Based Diagnostic Approach to Anaemia 21.2 Haemolytic and Autoimmune Haemolytic Anaemias 21.3 Membranopathies, Enzymopathies, PNH & Sickle Cell Disease
22 Haematology: Malignancy, Coagulation & Transfusion Medicine
22.1 Acute Leukaemias 22.2 Chronic Leukaemias & Myeloproliferative Neoplasms 22.3 Lymphomas & Plasma Cell Dyscrasias 22.4 Coagulation Cascade & Inherited Bleeding Disorders 22.5 Thrombocytopenia & Thrombotic Microangiopathies 22.6 Transfusion Products & Acute Transfusion Reactions
23 Psychiatry in General Medicine
23.1 Mood & Psychotic Disorders in Medical Patients 23.2 Psychiatric Emergencies & Substance Misuse 23.3 Mental Capacity & UK Mental Health Law
24 Geriatric Medicine
24.1 Comprehensive Geriatric Assessment, Frailty, Delirium & Falls 24.2 Polypharmacy, Deprescribing & Pressure Ulcers
25 Dermatology
25.1 Inflammatory Skin Disease, Immunobullous Disorders & Severe Drug Eruptions 25.2 Cutaneous Malignancy
26 Oncology & Palliative Medicine
26.1 Neutropenic Sepsis, Spinal Cord Compression & SVC Obstruction 26.2 Hypercalcaemia of Malignancy & Tumour Lysis Syndrome 26.3 Palliative Care & End-of-Life Symptom Control
27 Medical Ophthalmology
27.1 The Acute Red Eye & Sudden Painless Visual Loss 27.2 Retinopathy in Systemic Disease
18.1 Rheumatoid Arthritis: Pathophysiology, Clinical Features & Diagnosis
Key Takeaways Explain This Topic AI
Anti-cyclic citrullinated peptide antibody is about 95% specific for rheumatoid arthritis and predicts erosive disease better than rheumatoid factor.
Felty syndrome is rheumatoid arthritis with splenomegaly and neutropenia, and carries a high risk of recurrent bacterial infection.
Atlantoaxial subluxation is a life-threatening extra-articular complication requiring cervical spine imaging before intubation or general anaesthesia.
Last updated: September 2026
Inflammatory arthropathies represent a core examination domain in the MRCP(UK) Part 1 examination. Candidates must demonstrate detailed mastery of disease immunopathogenesis, autoantibody profiles, joint distribution, extra-articular manifestations, and guideline-directed pharmacotherapy, alongside the distinct clinical and radiographic features of the seronegative spondyloarthropathies.
1. Rheumatoid Arthritis: Pathophysiology & Immunogenetics
Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease characterized by persistent, symmetrical, invasive synovitis of diarthrodial joints.
Cellular & Molecular Pathophysiology
Loss of Self-Tolerance & Citrullination: Environmental triggers (most notably cigarette smoking and mucosal dysbiosis, particularly periodontal infection with Porphyromonas gingivalis ) activate peptidylarginine deiminase (PAD) enzymes. PAD converts positively charged arginine residues within self-proteins (vimentin, fibrinogen, alpha-enolase, type II collagen) into neutral citrulline .
Antigen Presentation & the Shared Epitope: Citrullinated peptides are avidly bound and presented by antigen-presenting cells expressing the HLA-DRB1 'shared epitope' —a conserved five-amino acid sequence (positions 70–74, such as QKRAA, QRRAA) within the peptide-binding groove of the HLA-DR4/DRB1*0401 and *0404 beta-chain. This elicits CD4+ T-cell activation (Th1 and Th17 phenotypes).
Humoral Immunity & Synovial Homing: Activated T cells stimulate autoreactive B lymphocytes to differentiate into plasma cells that produce anti-cyclic citrullinated peptide (anti-CCP / ACPA) antibodies and rheumatoid factor (RF) . Circulating immune complexes home to the microvasculature of the synovium, activating the classical complement pathway and recruiting monocytes and neutrophils.
Synovial Pannus Formation: The normally delicate, single-to-double-layered synovial lining undergoes marked hyperplastic proliferation, transforming into an aggressive, locally invasive fibrovascular tissue termed the pannus . The pannus consists of proliferated fibroblast-like synoviocytes (FLS), tissue macrophages, and neoangiogenic vessels driven by vascular endothelial growth factor (VEGF).
Cartilage Breakdown & Bone Erosion: Synovial macrophages and FLS release pro-inflammatory cytokines, predominantly tumour necrosis factor-alpha (TNF-α) , interleukin-1 (IL-1) , and interleukin-6 (IL-6) . These cytokines induce chondrocytes and FLS to secrete matrix metalloproteinases (MMP-1, MMP-3, MMP-13) , which degrade type II collagen and aggrecan, digesting articular cartilage. Concurrently, TNF-α and IL-6 massively upregulate receptor activator of nuclear factor kappa-B ligand (RANKL) on osteoblasts and T cells, driving the differentiation and activation of subchondral osteoclasts . Osteoclasts directly resorb bone at the synovial-bone junction, producing the hallmark marginal juxta-articular bone erosions.
- 2. Clinical Patterns & Characteristic Joint Deformities
- Joint Distribution & Symptoms
Pattern: Classically a chronic, insidious, symmetrical polyarthritis involving small and medium diarthrodial joints.
Predilection: Metacarpophalangeal (MCP) joints, proximal interphalangeal (PIP) joints, metatarsophalangeal (MTP) joints, and wrists. Later involvement includes knees, elbows, shoulders, ankles, and cervical spine.
Crucial Exclusions: Rheumatoid arthritis strictly spares the distal interphalangeal (DIP) joints and the thoracolumbar spine . Joint involvement at DIPs suggests osteoarthritis or psoriatic arthritis; thoracolumbar spinal involvement suggests spondyloarthropathy.
Diurnal Variation: Marked early morning joint stiffness lasting > 1 hour (frequently several hours), which characteristically improves with physical movement and warm showers , reflecting the "gelling" phenomenon of inflammatory synovial exudate (in stark contrast to osteoarthritis, where stiffness lasts < 30 minutes and worsens with prolonged exertion).
Characteristic Anatomical Deformities
Untreated or aggressive synovitis weakens surrounding tendons, ligaments, and joint capsules, precipitating signature anatomical deformities:
Boutonnière Deformity: Hyperflexion of the PIP joint accompanied by hyperextension of the DIP joint. Caused by rupture or avulsion of the central slip of the extensor digitorum tendon over the PIP joint, allowing the lateral extensor bands to slip volarly.
Swan-Neck Deformity: Hyperextension of the PIP joint accompanied by compensatory flexion of the DIP joint. Caused by stretching and laxity of the fibrocartilaginous volar plate at the PIP joint with contracture of intrinsic hand muscles.
Ulnar Deviation / Ulnar Drift: Subluxation and ulnar deviation of the fingers at the MCP joints, secondary to damage to MCP collateral ligaments and extensor tendon subluxation under the mechanical pull of flexor tendons.
Z-Deformity of the Thumb: Persistent flexion at the MCP joint with reciprocal hyperextension at the interphalangeal (IP) joint.
Piano-Key Sign: Ulnar styloid prominence and dorsal instability resulting from tenosynovitis of the extensor carpi ulnaris and destruction of the distal radioulnar joint (triangular fibrocartilage complex).
Atlantoaxial Subluxation (C1–C2 Instability): The transverse ligament of the atlas holds the odontoid process (dens) of C2 firmly against the anterior arch of C1. Pannus formation and erosive synovitis of the atlantoaxial synovial bursa weaken the transverse ligament, permitting anterior subluxation of C1 on C2. Clinically, patients present with occipital headache, neck stiffness, electric-shock sensations down the spine upon neck flexion (Lhermitte's sign), or progressive spastic quadriparesis. Mandatory exam rule: Patients with RA undergoing elective surgery require pre-operative flexion and extension lateral cervical spine radiographs to exclude atlantoaxial subluxation before endotracheal intubation, as neck extension during direct laryngoscopy risks fatal cervicomedullary cord transection.
3. Extra-Articular Manifestations & Felty's Syndrome
Extra-articular features reflect systemic immune-complex deposition and vasculitis, occurring almost exclusively in patients who are seropositive for RF and anti-CCP.
Systemic Organ Involvement
Rheumatoid Subcutaneous Nodules: Occur in 25–30% of seropositive patients, typically located over pressure points and extensor surfaces (olecranon process, extensor forearm, Achilles tendon). Histopathology demonstrates pathognomonic central fibrinoid necrosis surrounded by a radial palisade of CD68+ histiocytes (macrophages) and an outer mantle of lymphocytes.
Pulmonary Complications:
Interstitial Lung Disease (ILD): The most common pattern is usual interstitial pneumonia (UIP) (subpleural reticulation, basal traction bronchiectasis, and honeycombing on HRCT), carrying a poorer prognosis than the NSIP pattern seen in other connective tissue diseases.
Pleural Effusion: Typically asymptomatic, unilateral exudative effusion. Biochemical analysis reveals a pathognomonic profile: characteristically very low glucose (< 1.6 mmol/L or < 30 mg/dL) due to defective glucose transport across the inflamed pleura, marked elevation of lactate dehydrogenase (LDH > 1,000 IU/L), low pH (< 7.20), and low complement levels.
Rheumatoid Pulmonary Nodules: Discrete, well-circumscribed nodules in lung parenchyma; may cavitate. In coal miners with RA, the coexistence of multiple pulmonary rheumatoid nodules and pneumoconiosis is designated Caplan's syndrome .
Ocular Manifestations:
Episcleritis: Acute, painless or mildly uncomfortable segmental redness of the eye; engorged episcleral vessels move over the underlying sclera and blanch with topical phenylephrine 2.5%; benign and self-limiting.
Scleritis: Severe, deep, boring nocturnal ocular pain that radiates to the temple and periorbita; deep violaceous/bluish hue; vessels do not blanch with phenylephrine. Can cause scleral thinning and necrosis ( scleromalacia perforans ), presenting as anterior globe perforation; represents a medical emergency requiring high-dose systemic corticosteroids or biologics.
Keratoconjunctivitis Sicca (Secondary Sjögren's Syndrome): Occurs in 15–20% of RA patients, manifesting with xerophthalmia and xerostomia.
Rheumatoid Vasculitis: Severe, late-stage complication of high-titre seropositive disease. Manifests as digital gangrene, nailfold capillary infarcts, non-healing deep leg ulcers, palpable purpura, and mononeuritis multiplex (acute foot or wrist drop due to arteritis of the vasa nervorum).
Felty's Syndrome: A rare, severe complication occurring in long-standing, seropositive, nodular, erosive RA. Defined by the classic clinical triad:
- Rheumatoid arthritis (deforming, erosive, seropositive);
- Splenomegaly ; and
Neutropenia (absolute neutrophil count < 1.5 × 10⁹/L).
Patients have a dramatically increased susceptibility to recurrent, life-threatening pyogenic bacterial infections (skin, pulmonary sepsis) and develop hyperpigmentation and chronic lower extremity ulcers. Management prioritizes aggressive RA control with methotrexate or rituximab; G-CSF is reserved for severe neutropenic sepsis.
Secondary Amyloidosis (AA Amyloid): Prolonged active systemic inflammation elevates serum amyloid A (SAA), which deposits as beta-pleated sheets in renal glomeruli, presenting as progressive non-selective proteinuria, nephrotic syndrome, and renal impairment (diagnosed via Congo red staining exhibiting apple-green birefringence under polarized light).
- 4. RA Diagnostics & Radiographic Progression
- Diagnostic Serology & Acute Phase Reactants
Rheumatoid Factor (RF): An autoantibody (predominantly IgM ) directed against the Fc portion of human IgG . Present in 70–80% of RA patients (sensitivity ~75%), but specificity is modest (~70%). RF is positive in numerous non-RA conditions: primary Sjögren's syndrome (70%), SLE (20–30%), mixed cryoglobulinaemia (>90%), subacute bacterial endocarditis (SBE), chronic hepatitis C, tuberculosis, and 5% of healthy elderly individuals.
Anti-Cyclic Citrullinated Peptide (Anti-CCP / ACPA): Directed against citrullinated antigens. Sensitivity is comparable to RF (~75–80%), but specificity exceeds 95–98% . Anti-CCP appears years before clinical arthritis, correlates strongly with aggressive radiographic joint erosion, and serves as an independent prognostic marker for severe disease.
Inflammatory Markers: ESR and CRP are elevated, correlating with disease activity and used in composite scoring systems such as the DAS28 (Disease Activity Score evaluating 28 joints).
Radiographic Sequence on Plain Radiographs
Joint damage progresses along a predictable radiographic trajectory:
Soft Tissue Swelling: Earliest radiographic sign; fusiform swelling surrounding the joint capsule.
Periarticular Osteopenia (Juxta-articular Demineralization): Local hyperemia and cytokine-driven bone turnover deplete calcium in subchondral bone adjacent to the inflamed synovium.
Uniform Loss of Joint Space: Symmetrical destruction and thinning of articular cartilage across the entire joint cleft (in contrast to osteoarthritis, which causes focal, non-uniform joint space narrowing in weight-bearing zones).
Marginal Juxta-articular Bone Erosions: Pathognomonic focal bone loss occurring at the "bare areas" of the joint—regions within the joint capsule where bone is not protected by overlying hyaline cartilage.
Subluxation & Fibrous/Bony Ankylosis: Complete loss of joint architecture, joint displacement, and late fusion.